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When characterizing biomolecular interactions, avidity, is an umbrella term used to
describe the accumulated strength of multiple specific and unspecific interactions
between two or more interaction partners. In contrast to the affinity, which is often
sufficient to describe monovalent interactions in solution and where the binding
strength can be accurately determined by considering only the relationship between
the microscopic association and dissociation rates, the avidity is a phenomenological
macroscopic parameter linked to several microscopic events. Avidity also covers
potential effects of reduced dimensionality and/or hindered diffusion observed at or near
surfaces e.g., at the cell membrane. Avidity is often used to describe the discrepancy
or the “extra on top” when cellular interactions display binding that are several orders
of magnitude stronger than those estimated in vitro. Here we review the principles
and theoretical frameworks governing avidity in biological systems and the methods for
predicting and simulating avidity. While the avidity and effects thereof are well-understood
for extracellular biomolecular interactions, we present here examples of, and discuss
how, avidity and the underlying kinetics influences intracellular signaling processes.
Keywords: avidity, functional affinity, retention time, cellular avidity, modeling avidity
INTRODUCTION
Cell function relies on meticulously timed dynamic networks of biomolecular interactions taking
place in changeable cellular compartments with great variability in size, shape, pH, solute
concentration, and molecular crowding. All these parameters affect diffusion and reaction rates.
For instance, biomolecular interactions where one or more of the involved species are linked
to membranes will display very different binding strength and kinetics compared to interactions
occurring in solution within the cytosol. Here we use the term reaction to describe processes where
intermolecular interactions are formed or broken.
The strength of a biomolecular interaction is commonly referred to as the affinity. The affinity
is quantified as the equilibrium constant, Ka, for the reaction A + a ⇋ Aa (Figures 1, 2A). Often
the equilibrium constant for the reverse reaction, the dissociation constant, Kd, is used instead.
The microscopic rate constants for the above reaction are called the association rate constant, kon,
and dissociation rate constant, koff. The relation between these parameters and the equilibrium
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The association and dissociation rates depend on the type of
interaction and external physical properties (Calef and Deutch,
1983) and may span several orders of magnitude. kon ranges
from 109 M−1s−1 for the fastest diffusion limited reactions that
are enhanced by electrostatic interactions to 104 M−1s−1 for
slow reactions that often are governed by large conformational
changes (Schreiber and Fersht, 1996; Dogan et al., 2014). koff
depends on how fast the intermolecular interactions that stabilize
the complex are broken and typically ranges between 104 and
10−4 s−1. Similar to the large variation in the underlying rate
constants, the Kd vary over several orders of magnitudes from
around 1mM typically for protein-carbohydrate interactions to
around 1 fM for the binding of some metal ions. Consequently,
Kd values may be the result of very different microscopic
rate constants.
Determining affinities and underlying rate constants often
require the interacting molecules to be recombinantly expressed,
purified and titrations to be performed in an isolated and artificial
environment. In most cases, this approach provides affinities
and rate constants identical or comparable to the when the
interactions happen within or on a real cell. In other cases,
cooperativity, valency, and the local environment will result in
the “real” functional affinities being radically different from those
obtained by in vitro methods. The terms Functional affinity
and Avidity have been used interchangeably to describe how
the affinity changes when the molecules are observed in their
native environment. In particular, the intrinsic affinity and the
avidity will be radically different in multivalent systems where
both molecules have two or more linked binding sites. In such
cases low affinity (µM-mM) of the individual binding events can
translate into very a high (pM-nM) avidity for the multivalent
system. The local cellular compartment where the interaction
takes place can also greatly affect the avidity. In the following,
we will focus on how cooperativity, multivalency and diffusional
properties affect the avidity and the underlying microscopic
rate constants and review various routes for predicting and
modeling avidity. Finally, we present examples on how avidity
has been found to modulate intracellular interactions important
for maintaining proper cellular function and signaling.
MULTIVALENCY AND
COOPERATIVITY—HOW THEY ARE
DIFFERENT BUT NOT MUTUALLY
EXCLUSIVE
For a system to be cooperative, at least one of the interacting
partners e.g., a receptor must have multiple interaction sites
(be multitopic), which can be occupied by monomeric species
(Figure 1). In a cooperative system, binding of one ligand
must alter the affinity for the following binding event (Hunter
and Anderson, 2009). The most classical example of (positive)
cooperativity is hemoglobin, where binding of oxygen by one
of the four subunits promotes a conformational change, which
increases the affinity for oxygen of the adjacent subunit (Lee and
Karplus, 1983).
The simplest situation where cooperativity can be observed is
when a dimeric protein binds two ligands for which the overall
process may be described by the reaction: AA + 2a ⇋ AAaa. In
this case, the reaction scheme is slightly misleading as it suggests
that both ligands bind simultaneously. Even with a diffusion
limited on-rate the likelihood of two ligand molecules binding
at the same time is extremely low and the process will therefore
be very slow and practically never reach equilibrium. Sequential
binding of the two ligands is much more likely in a process
described by the reaction scheme shown in Figure 2B. If the
two binding events are independent and described by the same
rate constants, the process is completely un-cooperative and the
binding curve will be similar to the binding curve for the simple
1:1 binding above (Figure 2B, blue curve). If on the other hand
binding at one site leads to allosteric structural changes in the
other binding site that results in changed rate constants of the
second binding event, the system is cooperative. The cooperativity
can affect both the association and dissociation rates and be either
positive (higher affinity) or negative (lower affinity).
For a system to be multivalent, both the receptor and the
ligand must be multitopic (Figure 1). Multitopic species can be
either covalently attached (In a multitopic protein or as distinct
DNA binding motifs) or tethered (e.g., in a membrane) and for
this reason, the microscopic rate constants can be the result
of many different system or environmental specific parameters
i.e., Covalently attached multitopic binders may experience very
different degrees of flexibility and intermolecular dynamics and
membrane tethered ligands diffuse more slowly and only in
two dimensions compared to molecules in solution. Multivalent
systems can be either homovalent (identical binding sites) or
heterovalent (different binding sites) and also appear as positive
and negative cooperative (Figure 1). Thus, a homobivalent
system can have different rate constants for the first and
second binding event (Vauquelin et al., 2014). Cooperativity,
however, can be very hard to show in multivalent systems. The
simplest situation where multivalency can be observed is when
a homo-dimeric protein (AA) binds a homo-dimeric ligand
(aa) according to the scheme presented in Figures 1 and 2C. As
the heterogeneity or valency increases, the number of possible
bound states increases exponentially. Not considering any cross
binding (several receptors bound by the same ligand), the
number of possible states can be estimated by the expression
nstates (n) = 1 − n + n2n. For a heterobivalent interaction,
the number of possible states is thus 7, which increases to
156 for a pentavalent interaction (Erlekam et al., 2019). The
initial binding step of any multivalent interaction is governed
by the intrinsic association rate constant. After binding of the
first ligand, the second ligand is spatially restricted and in close
proximity to its target. The effect of this forced proximity can
be formalized into a local concentration, [L], and therefore
the effective association rate of the second ligand binding
will proceed much faster than the first (Kramer and Karpen,
1998). In the case of dissociation of only one ligand from its
target, which is independent on the local concentration and
governed the intrinsic dissociation rate, koff, the ligand will still
maintain the high local concentration and the probability of
rebinding to the same or other sites in the proximity of the
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FIGURE 1 | Schematic figure showing monovalent, cooperative and homo- and heterobivalent reactions. In cooperative binding either one or both the association
and dissociation rates of the second binding step may be modulated by cooperativity factors c1 and c−1. Only cases where only one of the interacting species are
multitopic and where the reaction is not diffusion limited allows for accurate determination of the cooperativity. In multivalent binding, both of the interacting species
are multitopic. For simplicity we have presented reaction schemes for both a homo- and heterobivalent interactions. In these cases the association rate of the second
binding step is modulated by the local concentration, [L], and an empirical penalty factor, f. Multivalent interactions can also be cooperative but the direct effect is
difficult to determine accurately.
multivalent molecule will be high. For this reason, multivalent
interactions can have extremely high residence times and may
be virtually irreversible (Vauquelin and Charlton, 2013; Huskens,
2018). In almost all cases, the local concentration will be
much higher than the bulk ligand concentration (typically
around µM) and therefore the rebinding event will be favored
over the association of a third multivalent molecule (ternary
complex). In such cases, the intermediate product aaAA will
be short-lived and the system will quickly equilibrate and
form the closed binary complex where each binding site on
aa interacts with a binding site on AA. We call this complex
aAAa. If, however, the local concentration of free aa is very
high or the formation of the multivalent complex is very
unfavorable (f is high), the ternary complex, aaAAaa, will be
populated. Such a multivalent system will take much longer to
equilibrate and consequently, biological multivalent systems may
never fully reach equilibrium (Vauquelin and Charlton, 2013).
The occupancy and life-times of the intermediate aaAA and
ternary aaAAaa products, can be of great biological significance
(Erlendsson et al., 2019).
HINDERED DIFFUSION AND REDUCED
DIMENSIONALITY
In a real biological system knowing the free receptor and
ligand concentrations is not straightforward. Cells and tissue
are highly compartmentalized, and fluctuations in temperature,
pressure, ionic concentrations, pH and oxidation levels as
well as the dimensionality and molecular composition of the
compartment are crucial regulators of cellular function. All of
these parameters govern the diffusional properties and flux of
molecules and therefore also the avidity of both mono and
multivalent interactions through modulation of the effective
association rate constants (Goldstein and Dembo, 1995). For
example, interactions taking place in confined protein dense
areas beneath or above the plasma membrane (immunological
synapses, synaptic clefts or the postsynaptic density) will often
suffer from reduced dimensionality and hindered diffusion
which can result in a concentration gradient between membrane
proximal and distal regions (Vauquelin and Charlton, 2010).
Coombs and Goldstein (Goldstein andDembo, 1995; Coombs and
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FIGURE 2 | Simulations of binding curves. (A) Equilibrium binding curve for a monovalent ligand binding to a monovalent receptor. (B) Equilibrium binding curves for a
monovalent ligand binding to a dimeric (or divalent) receptor in case of negative cooperativity, Kd1 = 0.01Kd2 (red), no cooperativity (blue) and positivity cooperativity,
Kd1 = 100Kd2 (green). In the case of cooperativity, the scale on the x-axis is calculated with K =
√
Kd1Kd2. For the non-cooperative case K = Kd. (C) Model for
(Continued)
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FIGURE 2 | binding of a homo-divalent ligand to a homo-divalent receptor. All steps are assumed to have the same microscopic rate constants, k1 and k−1. The
intra-molecular binding reaction AAaa to aAAa is also controlled by the effective ligand concentration [L] and the empiric proximity factor f that accounts for steric
restrictions on the intramolecular process compared with the intermolecular process. (D) For the intramolecular binding to a receptor on a surface, the local
concentration is calculated as the concentration of the ligand in half-sphere with a radius equal to the distance between two binding sites on the ligand when it is fully
extended. (E) Binding curves for the model in c with [AA] = 0.1 nM k1 = 1.85 × 105 M−1min−1 and k−1 = 8.5 × 10−3 min−1 at three different values of f and [L] =
136µM simulated after 1,200min equilibration. (F) Same as in (E) except that the curves were extracted after 120min. (G) Time traces of binding and dissociation for
the model in (C) at three different ligand concentrations, with f = 1,000 and other parameters as in (E). For comparison the time trace for at 1 to 1 binding reactions
with kon = 1.85 × 105 M−1min−1 and koff = 8.5 × 10−3 min−1. (H) Same as in (G), except f = 35. ll simulations were performed with COPASI (Hoops et al., 2006).
Goldstein, 2004) proposed that the effect of hindered diffusion
can be approximated by calculating modulated rate constants

















Where k+ is the average diffusion-limited association constant
within the compartment and k+ is the average diffusion-
limited rate constant for leaving the compartment. Using these
modified rate constants in simulations Vauquelin et al. showed
that hindered diffusion can increase the time before equilibrium
is reached and prolong the residence time of the ligands close
to their targets much like multivalent rebinding (Vauquelin
and Charlton, 2013). On the other hand, the avidity can be
decreased by hindered diffusion when the ligand concentration
and flux is lower than the association rate. Consequently,
hindered diffusion and reduced dimensionality can indirectly
either enhance or decrease the avidity, even in monovalent cases.
The concentrations of receptors and ligand and their diffusional
properties are compartment specific and therefore the avidity can
be hard to predict at e.g., neuronal synapses or immunological
synapses (Caré and Soula, 2011; Eloul and Compton, 2016; Eloul
et al., 2016; Li et al., 2018).
MEASURING AND MODELING AVIDITY
In practice it is not straight forward to get a clean readout
of the avidity of multivalent systems. When the multitopic
species are covalently attached and not tethered in the
plasma membrane, the underlying kinetics of multivalent
interactions can typically be assessed by in-solution fluorescence
methodologies, such as fluorescence anisotropy, stopped flow
fluorescence, FRET and fluorescence correlation spectroscopy.
Obtaining the microscopic rate constants requires purification
of one or more of the species and also require systematically
removing or mutating each individual binding site to get the
microscopic rate constants.
When one of the multitopic species are not covalently
attached, surface plasmon resonance (SPR) (Lynch et al., 2014;
Akkilic et al., 2019; Porkolab et al., 2020) is currently most used.
SPR is label-free and allows for immobilization of themonovalent
species (the receptor) at a given density on an activated surface.
Following immobilization, the multitopic ligand can then be
titrated over the receptor surface. By varying both the density
of the receptor, and the concentration and flow of the ligand
this can provide both the intrinsic affinity and avidity of the
interaction. Another related label-free method is the Quartz
crystal microbalance (QCM-D) (Decker et al., 2003; Johansson,
2010) which can be utilized for obtaining affinities over a wide
range of biomolecular interactions. Both systems can deal with
purified receptors reconstituted in membrane mimetics and also
allows for formation of lipid bilayers (Cho et al., 2010; Patching,
2014; Bocquet et al., 2015; Brun et al., 2015; Parkkila et al.,
2018; Iorio and Huskens, 2020). Other more recent methods
for measuring avidity use confocal or TIRF microscopy to
obtain avidities in the native cellular environment (Oh et al.,
2012; Erlendsson et al., 2019). While these systems are more
heterogenous and the results harder to interpret, they maintain
the complexity and integrity of a native cellular system, and also
allow for probing ligand binding to both intra and extracellular
membrane tethered multivalent species. Finally, atomic force
microscopy (AFM) has also been utilized to obtain avidities
of antibody-antigen interactions or cell-cell adhesion strength
(Wojcikiewicz and Moy, 2005; Zhang et al., 2020).
The avidity is a complex entity governed by the valency,
cooperativity and the local compartment. Therefore, to
model the avidity of a receptor-ligand interaction several
factors must be considered: (1) The intrinsic affinity of
the involved individual complex(es), (2) the valency of the
interaction partners, (3) structural re-arrangements of proteins
(conformational exchange), and (4) diffusional properties and
reduced dimensionality. These contributions are not easily
deconvoluted, but a detailed experimental analysis combined
with a thermodynamic or kinetic model can identify rate limiting
steps and the sensitivity of the system to changes in intrinsic
affinity. Using thermodynamics to describe avidity is particularly
useful when the valency, n, is high (> 5). Thermodynamics,
however, only give steady-state equilibrium information. Kinetic
models have the advantage that also non-equilibrium situations
can be described. A drawback of using reaction kinetic models,
is that for systems with high valency the differential equations
(see Equations 7–11) become very complex and computationally
challenging to analyse (Vauquelin and Charlton, 2013). Below we
will describe how thermodynamic models and reaction kinetic
models can be used to predict and model the avidity.
The Thermodynamic Model
For a multivalent receptor-ligand (denoted R and L, respectively)
interaction process, like for any other process at constant
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pressure, the Gibbs free energy consists of an enthalpic and an
entropic contribution connected by the fundamental relation
1G0 = 1H0-T1S0. Considering the contributions to each of
these terms will provide some insight into what determines the
avidity of a multivalent reaction. First, it is important to clearly
define the reaction for which 1G0 is calculated. An n-valent
binding reaction may be written as:
R+ L = [RL(1)+ RL(2)+ . . .RL(n− 1)+ RL(n)] (4)
where the number in parenthesis is the number of ligand sites
bound to the receptor. For this reaction, the total change in
free energy, 1G0total, for the process could be defined as the
difference in energy between the free species and the fully bound
state where all n binding sites are occupied corresponding to
the process R + L = RL(n). 1G0total is then a result of all
the individual contributions from the n binding sites. In some
instances, the avidity is defined as the equilibrium constant
for this process, i.e. Kav = exp(−1G0total/RT) (Mammen and
Choi, 1998; Krishnamurthy et al., 2006), which makes sense
if the biological effect depends on complete binding of all n
binding sites.
However, if n is large, the intermediate states will dominate,
and the fully bound state will only be sparsely populated. In
addition, many binding assays measure the total concentration
of bound receptors (i.e., the sum of all bound states) and
the concentration of free receptor. In these cases, the avidity
constant, Kav, can be defined as the equilibrium constant for the
equilibrium between free and any bound receptor species (Kitov















where i is the number of occupied sites on the receptor. For each
of the bound states the binding energy can be expressed as a
function of i (Krishnamurthy et al., 2006):















− RTln (i) (6)
In the last part of this equation the energy is broken down
to six individual terms. The value of the individual terms
can be difficult to determine, particularly for biological ligands
where compounds with different andwell-defined valency cannot
readily be produced. Still, discussing how each term contributes
to 1G0
multi
gives an understanding of the molecular mechanisms
underlying the magnitude of the avidity effect. The first term
in equation 6 is simply the binding energy for the receptor
interacting with i monomeric ligands that each has a single
binding site. When the ligand is also multitopic, only the first
interaction thermodynamically resembles the interaction of a
monomer. For the remaining i – 1 interactions the binding
energies are modified by the terms in squared brackets. The first
of these terms is the rotational and translational entropy. This
entropy is only lost in the first interaction and therefore should
be subtracted –(–T1S0) from the remaining i – 1 interactions.
The second term is the enthalpic contribution from interactions
between the linker parts of the ligand and the receptor that could
be either favorable or unfavorable. To connect i binding sites, i
– 1 linkers are needed and therefore this is added (i – 1) times.
The third term is the conformational entropy of the linkers,
which often will only be marginally affected in the first binding
event. For the i – 1 subsequent binding events, the change will
be much larger as the binding sites become fixed relative to each
other. Typically, the 1H0linker and 1S
0
linker terms will be highly
correlated through entropy-enthalpy compensation (Williams
et al., 2004; Teilum et al., 2009). However, depending on specific
conformational changes occurring in the linker in each binding
step, the specific enthalpic and entropic contributions are hard
to predict (Teilum et al., 2009). The last term in the brackets is
the effect of cooperativity, which is normally small relative to the
other terms (Krishnamurthy et al., 2006; Fasting et al., 2012). The
very last term relates to the degeneracy,I, of the system, which is
how many different ways the i interactions between the receptor
and the ligand can be formed. The degeneracy can be considered
an additional entropy term and is called the avidity entropy in the
literature (Kitov and Bundle, 2003; Martinez-Veracoechea and
Leunissen, 2013). In detailed simulations of avidity, it is often
useful to apply statistical thermodynamics. Please see (Xu and
Shaw, 2016; Curk et al., 2018) for examples hereof.
A much simpler but less informative evaluation of the avidity
in a multivalent system, which is however practically tractable, is
to calculate the enhancement of the affinity relative a monovalent
receptor-ligand interaction as β = Kav/Kmono. Enhancements in
the range β = 103-1017 have been observed for even simple di-
and tri-valent systems (Rao et al., 2000; Erlendsson et al., 2019).
The Reaction Kinetic Model
Whereas, the thermodynamic description of a receptor-ligand
interaction provides insight into the forces that drive the
reaction, it does not tell about the order of the events. For
this a kinetic model is necessary. Simulations of the kinetic
models rely on sets of differential equations representing each
state as a function of time (see below). We used kinetic
simulations to obtain binding curves shown in Figure 2. All
equations represents one-step, reversible interactions obeying
the laws of mass-action. By consecutively solving the differential
equations in parallel, all states can be monitored over time
(Hoops et al., 2006; Vauquelin and Charlton, 2010, 2013). As
kinetic models easily become very complex and difficult to
interpret we here consider the interaction of a homodimeric
receptor (AA) with a dimeric ligand (aa). We assume that
there is no allostery and that both sites on the receptor
and the ligand are identical. The reaction scheme is shown




= k−1 [aaAA]+ k−1 [AAaa]− 2 k1 [aa] [AA](7)
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d [aaAA]
d(t)































[AAaa]− 2k−1 [aAAa] (10)
d [aaAAaa]
d(t)
= k1 [aAA] [aa]+ k1 [AAaa] [aa]
−2k−1 [aaAAaa] (11)
There are two steps that depend on the concentration of free
ligand; (i) the initial interaction between AA and aa to form
the binary AAaa (or aaAA) complex and (ii) the binding of
a second ligand to form the ternary complex aaAAaa. This
aaAAaa state will form when the concentration of the free
ligand aa is high in solution. At low concentrations of aa,
intra-complex formation of an interaction between the second
subunit on the protein and the second subunit on the ligand
(aAAa) may be more favorable than formation of the ternary
complex. The formation of this species is dependent on the
effective local concentration experienced by the second binding
site on the protein relative to the concentration of the ligand
free in solution. In the model in Figure 2C the effective local
concentration is expressed as [L]/f. For a ligand bound to a
receptor at a membrane surface, [L], is the concentration of
the second binding site of the ligand in a half-sphere centered
at the occupied binding site of the ligand and with a radius,
r, equal to the distance between the two binding sites on the
ligand (Figure 2D). f is an empirical penalty factor that accounts
for geometrical constraints on where in the half sphere the free
ligand site may actually be found. If the local concentration
of the second binding site is very high compared to the free
concentration of ligand and also large compared to k1/k−1 the
closed dimeric complex (aAAa) will dominate. In a titration
experiment, this situation corresponds to the black line in
Figure 2E where f=1, which also results in a very high avidity.
The ternary complex will only become populated at extreme
ligand concentrations and the binding curve resembles that of
a system in negative cooperativity. If on the other hand the
effective local concentration of the second ligand binding site
is very small, the closed dimeric complex will not be populated
before the concentration of free ligand favors formation of the
ternary complex (Figure 2E, red line). For the less strong local
concentrations (high r of f ) both the closed dimeric complex and
the ternary complex are populated, and the dominating species
changes over a relative narrow concentration range, but still with
a two-step behavior similar to negative cooperativity (Figure 2E,
magenta line).
The kinetics of the binding between a dimeric protein and
a dimeric receptor (Figure 2G, red curves) is clearly different
from the kinetics of a single step binding between two monomers
(Figure 2G, black dashed curve). It is particularly clear that the
dissociation kinetics in addition to being biphasic also becomes
very slow as a consequence of rebinding of the partly dissociated
ligand. If the closed dimeric complex is favored (by lowering f to
35 as in Figure 2H) the dissociation is extremely slow and will
take several days to complete (Radnai et al., 2010; Li et al., 2014;
Xu and Shaw, 2016; Erlendsson et al., 2019; Errington et al., 2019;
Sørensen and Kjaergaard, 2019).
Moreover, the time before the system reaches equilibrium
increases for the dimeric binding models when f is decreased.
This is particularly pronounced at low ligand concentrations.
Indeed, for a binding reaction following the model in Figure 2C,
the outcome of a titration experiment is very different if samples
are equilibrated for 2 h (Figure 2E) or 20 h (Figure 2F). Thus,
many biological multivalent interactions will effectively be non-
equilibrium binding events. With a slow macroscopic association
rate, it may in some cases take several hours or even days to reach
equilibrium (Vauquelin and Charlton, 2013).
AVIDITY IN BIOLOGY
Avidity was initially conceptualized to explain how neutralizing
bivalent antibodies increase efficacy in vivo when compared to
the affinity experimentally determined in vitro (Finkelstein and
Uhr, 1966; Hornick and Karuch, 1972; Karush and Hornick,
1973), and the theoretical frameworks are well adapted to model
antibody avidity and for designing potent multivalent antibodies
(Cuesta et al., 2010; Baran et al., 2017; Einav et al., 2019).
Antibodies have low valences (up to 10 for IgM) and the
interactions themselves are highly dependent on the abundance
and spatial organization of their Fc receptor targets as the
two binding sites of a typical bivalent IgG antibody are no
more than 10 nm apart. Having a short distance between the
binding sites results in very high local concentrations and thus
the rebinding probability governing the second binding event
becomes very high.
Other well-studied multivalent systems are cell-cell, cell-
bacteria and virus-host interactions (Westerlund and Korhonen,
1993; Choi et al., 1996; Kitov et al., 2000; Zhang et al., 2002;
Sieben et al., 2012; Xiong et al., 2013; Einav et al., 2019).
The avidity of these systems depends largely on the abundance
and organization of the relevant receptors on the cell surfaces
(Xu and Shaw, 2016). Cells and bacteria display thousands of
receptors facilitating a wealth of homo- and heteromultivalent
interactions. The intrinsic affinities of these systems are often
low (mM) but can be higher depending on the sparsity of the
receptors. Often 10–1,000 receptors are involved in forming
tight connections between cells and it is not unusual to have
avidities 1–10 million-fold higher than the intrinsic affinity of
the monovalent ligand (β of 106-107). Some of these ultrahigh
avidity interactions display high degrees of degeneracy and are
virtually not reversible processes. They are only broken by shear
force, changes in local environment (pH, ionic strength), or
enzymatic cleavage.
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Less degenerate complexes rely on strict spatial coordination
of multiple interaction pairs. In such cases even subtle changes in
intrinsic affinities or geometry may change binding preference.
This can be the case for some virus-host interactions where the
mutational rate is high, and the density of glycoproteins and
receptors can vary significantly across different viral strains and
cell types. As an example, it was shown that for avian influenza
H5N1 even small changes in haemagglutinin-SA binding affinity
is sufficient to switch the binding preference of the virus from
avian receptors to human receptors (Xiong et al., 2013).
The above types of multivalent systems have been thoroughly
reviewed in several excellent papers (Mammen and Choi, 1998;
Kitov and Bundle, 2003; Fasting et al., 2012) and while they are
indeed very diverse in terms of number of molecules, specificity
and affinity, they are all extracellular.
INTRACELLULAR AVIDITY
Many intracellular proteins are composed by multiple domains
(Sriram et al., 2009; Wu, 2013). However, the effect of
avidity on the intracellular interactome and its spatio-temporal
regulation has been less well-described compared to the
extracellular examples above. In fact, the functional consequence
of multivalency in intracellular signaling complexes has been
largely neglected and few reports directly addresses the existence
or origin of the avidity. As for extracellular interactions,
multivalency, hindered diffusion and reduced dimensionality
maintains high effective concentrations and increases residence
time of the involved complexes. In particular, large cellular
structures such as the plasma and intracellular membranes, DNA
and the cytoskeleton provide perfect frameworks for tethering
binding sites which can be coordinated by bi- or multivalent
binders. Moreover, intracellular multivalent interactions are to a
larger extent heterovalent, which greatly enhance the specificity,
and change the retention time at sites where two ligands are
clustered compared to when they are not. In membranes, also the
local concentration of potential binding sites and thereby also the
avidity and retention time is largely affected by diffusion rates of
the ligands within the membrane.
From a biological perspective, multivalency and resulting
avidity can dramatically alter cellular function. As discussed
above, multivalent complexes can have very long retention
and equilibration times which can control both duration and
strength of a given cellular process. Gene transcription and
transcriptional regulation are good examples of this as DNA
contains thousands of different specific and repeatable binding
motifs for transcription and transcriptional regulation of genes.
Although binding motifs can be more or less exposed as a
consequence of DNA compaction/condensation, the binding
motifs are fixed relative to each other and are often located
close together yielding very high local concentrations (0.1–1M).
An example is the Escherichia coli RNA polymerase (RNAP)
which binds (at least) three sites designated −35, −10, and
upstream element, UP. The RNAP binds different promotors
with avidities spanning three orders of magnitude depending
on the primary base sequence and the space between the sites
(Dayton et al., 1984; Liu et al., 2003). A recent study by Einav
and Phillips analyzed gene expression of over 10,000 promoters
spanning all possible combinations of a set of regulatory elements
(Urtecho et al., 2019). They showed that discrepancies between
experimental and predicted expression levels could be explained
by applying a multivalent model describing how the RNAP can
buffer mutations but also that too tight binding can inhibit gene
transcription (Einav and Phillips, 2019). Moreover it was also
shown that the local concentration of RNAP leads to different
mechanisms of diffusion of RNAP which has a dominating effect
on how specific target sites are located (Wang et al., 2013).
Another example more classical example is the Retinoid
X Receptor transcription factor (RXR). RXR belongs to the
family of nuclear hormone receptors (NHR) which are ligand-
activated transcription factors that regulate gene expression by
interacting with specific repetitive DNA sequences (hormone
receptor elements; HREs) upstream of their target genes. NHRs
bind as dimers with each monomer recognizing a six base pair
sequence of DNA. The intrinsic affinity of the RXR monomer
for DNA is roughly 1µM whereas the RXR homodimers vary
from 10 to 160 nM for different nucleotide sequences (Osz et al.,
2015). Also here, the transcription level scales non-linearly with
the avidity and it has also been found that RXR tetramers may in
some cases be required for transcription to take place (Chen and
Privalsky, 1995).
Similar to DNA, cellular membranes are capable of
tethering and clustering ligands for multivalent binders.
Like protein-nucleic acid interactions above, interactions with
membranes themselves (protein-lipid interaction) or membrane
embedded ligands (protein-protein interaction) are sensitive to
compositional and structural changes. Additionally, membranes
are fluid and ligands diffuse within the membrane with rates
much slower than in solution and only in two dimensions
(Javanainen et al., 2017).
A vast variety of multivalent molecules interact with
membranes or membrane tethered ligands. Scaffolding proteins
are multidomain molecular hubs important for many cellular
processes including cell-cell signaling, intracellular signaling
and assembly line processes. Cellular localization of receptors,
cellular adhesion molecules and their intracellular association
with enzymes or downstream signaling molecules are largely
controlled by specific interactions with scaffolding protein
domains (Good et al., 2011). Scaffolding protein domains are
usually protein-protein interacting modules but are also in
some cases capable of specifically binding lipids or even cellular
structures (Erlendsson and Madsen, 2015; Herlo et al., 2018).
Canonical scaffolding domains include; SH2/3, PX, PH, and PDZ
domains. Scaffolding proteins such as GRIP14 and MUPP115
contain almost exclusively PDZ domains (7 and 13, respectively)
arranged like beads on a string, whereas PSD-95, CASK, and
MAGI contains at least one PDZ domain, and one or more
SH3/WW domains. The N-BAR family of scaffolding proteins
including PICK1 and endophilin also comprises a coiled-coil
dimerization/oligomerization domain.
One study used TIRFmicroscopy to probe the nearmembrane
dwell-time (retention time) of the scaffolding protein Grb2,
containing two SH3 domains and one SH2 domain. The SH2
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domain binds to phosphotyrosines whereas the SH3 domains
binds proline rich regions. In good agreement with the rebinding
model they found that Grb2 resides significantly longer than
predicted from the intrinsic chemical dissociation rate constant
between phosphotyrosine and the Grb2 SH2 domain. It was
also found that the dwell time is positively correlated with
the local density of receptor tyrosine kinase phosphorylation
(Oh et al., 2012).
For PICK1 and PSD95 we have recently used a cell membrane
sheet assay to investigate the ligand binding of PICK1 and PSD-
95 on the inner leaflet of the plasma membrane (Erlendsson
et al., 2019). These experiments showed that PICK1 and PSD-
95 bind their partner proteins with avidities up to two orders of
magnitude better than the intrinsic affinities previously observed
using other binding assays. We also found that changing the
intrinsic affinity from 1 to 10µM, resulted in a complete switch
between a multivalent and monovalent interaction mode at
physiological protein concentrations, and that only one of these
modes resulted in recycling of ligand receptors. Combining
these experiments with kinetic simulations similar to those
presented above, we were able to demonstrate clear biphasic
behavior of this system and also determine the microscopic
reaction rates governing the avidity. In good agreement with
theory we showed that the retention time and equilibration
time becomes extremely long (t1/2, ∼ 375min, kon,av ∼ 25min
at a concentration of 5 times Kav) (Erlendsson et al., 2019).
From this insight, a high avidity bivalent inhibitor of PICK has
recently been developed that alleviate neuropathic pain in rats
(Christensen et al., 2020).
FLEXIBLE MULTIVALENT SYSTEMS
The examples above relate to multidomain proteins binding
to other multidomain or tethered ligands with highly specific
binding motifs, however, recently the principles of avidity and
multivalency has also been expanded to include interactions
involving fully flexible systems such as intrinsically disordered
proteins (IDPs), and systems with less specific binding sequences
e.g., phosphorylation sites or short linear motifs (SLiMs) (Mittag
et al., 2008; Tompa, 2014; Bugge et al., 2020). SLiMs do not
have extensive interaction interfaces to induce high enthalpy so
instead SLiM-containing IDPs often utilize multiple motifs to
participate in multivalent interactions (Hayama et al., 2018).
One example is the bivalent 14-3-3 protein scaffold,
which interacts with a wide range of signaling proteins via
phosphorylated serine residues. Ligands include the Cystic
Fibrosis Transmembrane conductance Regulator (CFTR) and
Leucine-Rich Repeat Kinase 2 (LRRK2) featuring nine and six
14-3-3 binding motifs, respectively. The avidity gain spans 3
orders of magnitude for CTFR (1.1 × 10−3-2.9 × 10−6 M) but
almost 6 orders of magnitude for LRRK2 (8.6 × 10−4 to 2.8 ×
10−10 M). This difference is strongly correlated with the effective
concentration of the binding sites, which ranges from 1.2 to
110mM, and the authors find a strong but different enthalpy–
entropy correlation for the two systems (Stevers et al., 2018).
Another example relates to transport across the nuclear
pore complex (NPC). The central channel of the NPC is lined
by intrinsically disordered regions of Phe–Gly nucleoporins
(FG Nups) which form a selective permeable barrier for
macromolecular transport. FG Nups typically contain 5–50 Phe-
Gly motifs separated by spacer residues. In spite of many
FG repeats the avidity is not as dramatic as for the other
multivalent systems presented above. The intrinsic affinity
between the nuclear transport factor 2 (NTF2) and one FG
motif is ∼3mM which increases to ∼0.5mM for four FG
motifs, but does not increase any further if additional FG motifs
are introduced. Similar to the 14-3-3 proteins, the enthalpy–
entropy balance prevents strong avidity which enables rapid and
reversible interactions necessary for transport across the NPC.
However, the enthalpy–entropy balance can be compensated
by a high local concentration of FG motifs which permits
higher frequency of contacts and thereby longer residence time
(Hayama et al., 2018).
LINKERS AND LOCAL CONCENTRATIONS
In the thermodynamic model, the avidity contribution from
interactions between the linker(s) of the ligand and the receptor
are given by its enthalpy, 1H0linker, and conformational entropy,
1S0linker (Kitov and Bundle, 2003; Krishnamurthy et al., 2006;
Kane, 2010). In the kinetic models, the length of the linker(s)
dictates the minimum local concentration (the binding sites
might be closer in space than the reach of the linker) and
the conformational enthalpy and entropy is embedded in
the composite penalty parameter, f. For most flexible linkers
the enthalpic interactions between the linker and the protein
binding is neglectable and therefore the linker contribution
to the overall avidity is almost entirely entropic. For fully
flexible linkers the change in conformational entropy is low
(Krishnamurthy et al., 2007), but may increase significantly if
the valency is high (Hayama et al., 2018), or if the composition
or the structure of the peptide or nucleic acid changes (van
Leeuwen et al., 1997; Einav et al., 2019; Sørensen and Kjaergaard,
2019). In most cases multivalent ligands with flexible linkers
longer than the distance between the binding sites will be
less effective in binding as the distance increases. For this
reason, using local concentrations calculated based on the
distance between the binding sites gives a good estimate of
the theoretical avidity of the system (Krishnamurthy et al.,
2007).
However, when calculating the local concentration, we
make the assumption that all distances within the reach of
the multivalent molecule are equally well-populated. This is
essentially not the case. In a bivalent system, shortening or
lengthening the distance between available binding sites changes
the effective local concentration that modulates the secondary
binding event. Shorter distances translate into higher effective
local concentrations and vice versa. In situations where binding
is not limited by the availability of binding sites, determining
which local concentration zones are mostly populated depends
ultimately on the flexibility and chemical composition of the
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linker itself. Multivalent systems can range from disordered,
where all configurations are equally favored, to rigid where only
certain configurations are allowed.
To more explicitly take into account the steric effects of the
linker when calculating the local concentration, Errington et al.
recently devised a more sophisticated model taking into account
the uneven linker end-to-end distribution and the probability
of binding between the ligand and receptor (Errington et al.,
2019). Here the effective concentration (local concentration)
of all receptor/ligand pairs can be calculated by using the
probability density functions (PDF). PDFs and therefore specific
local concentrations can be generated for each individual
states/configuration within the multivalent binding network.
This approach was able to accurately predict experimental
avidities and model microstates with different abundances
and lifetimes.
EMERGING CONCEPTS AND FUTURE
PERSPECTIVES
In addition to the effects we have described in this review,
multivalency may also lead to a series of other properties not
observed for monovalent protein-ligand complexes. Designing
multivalent drugs have huge potential and is already widely
applied (Mourez et al., 2001; Kim et al., 2008; Bach et al.,
2012; Dubacheva et al., 2015; Karlsson et al., 2015; Maric et al.,
2015; Einav et al., 2019; Christensen et al., 2020; Ortega et al.,
2020). Within the past 5 years it has become increasingly
clear how multivalent interactions of particularly RNA and
IDP’s drive liquid-liquid phase separations (Cohan and Pappu,
2020; Conicella et al., 2020; Guillén-Boixet et al., 2020; Martin
et al., 2020; Ryan et al., 2020). Multivalent interactions can also
give rise to superselectivity of synthetic ligands where several
weak binding sites are linked together (Martinez-Veracoechea
and Frenkel, 2011; Dubacheva et al., 2015). These systems
shift between bound and unbound states over a very narrow
concentration range and have great potential for use as detectors
in nanodevices (Wang et al., 2010, 2020; Foster et al., 2017; Curk
et al., 2020) much similar to what can be achieved by super
cooperative aptamers and proteins (Ortega et al., 2020).
In this review, we have shown examples of biological systems
inside cells where the high avidity and long residence time typical
for multivalent interactions are important for the biological
function. Intracellular interactions are particularly challenging
to analyse as it poses a great technical challenge to titrate
an intracellular receptor with ligand without disturbing the
native environment. This is important e.g., in the postsynaptic
density wheremany supramolecular complexes form that depend
on membrane embedded receptors and the right composition
and topology of the membrane. Developing methodology
for extracting accurate thermodynamic data in native-like
environments will be a great step toward a more detailed
understanding of how the activity of such complexes are
regulated. Future experimentsmaking use of molecular dynamics
simulations in appropriate force fields could also potentially
allow for even more accurate predictions of local concentrations
and regulation by multivalency.
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